Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;17(2):92-8.
doi: 10.4103/0972-5229.114829.

Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children

Hanan M Hamed  1 , Seham Awad El-Sherbini, Nahla A Barakat, Tarek M Farid, Enas Abdel Rasheed
Affiliations

Serum cystatin C is a poor biomarker for diagnosing acute kidney injury in critically-ill children

Hanan M Hamed et al. Indian J Crit Care Med. 2013 Mar.

Abstract

Background: Accurate diagnosis of acute kidney injury (AKI) is problematic especially in critically-ill patients in whom renal function is in an unsteady state.

Aim: Our aim was to evaluate the role of serum (S.) cystatin C as an early biomarker of AKI in critically-ill children.

Subjects and methods: S. creatinine and S. cystatin C were measured in 32 critically-ill children who were at risk for developing AKI. AKI was defined by both: Risk,-injury,-failure,-loss, and-endstage renal disease (RIFLE) classification and glomerular filtration rate (GFR) <80 ml/min/1.73 m(2). GFR was estimated by both Schwartz formula and S. cystatin C-based equation.

Results: S. cystatin C was not statistically higher in AKI patients compared with non-AKI by RIFLE classification (median 1.48 mg/l vs. 1.16 mg/l, P = 0.1) while S. creatinine was significantly higher (median 0.8 mg/dl vs. 0.4 mg/dl, P = 0.001). On estimating GFR by the two equations we found, a lag between rise of S. cystatin C and creatinine denoted by lower GFR by Schwartz formula in four patients, on other hand, six patients had elevated S. cystatin C with low GFR despite normal creatinine and GFR, denoting poor concordance between the two equations and the two markers. The ability of S. creatinine in predicting AKI was superior to S. cystatin with area under the curve (AUC) 0.95 with sensitivity and specificity (100% and 84.6%, respectively) using the RIFLE classification. The same findings were found when using Schwartz formula.

Conclusion: S. cystatin C is a poor biomarker for diagnosing AKI in critically-ill children.

Keywords: Cystatin C; risk-injury-failure-loss-end stage renal disease criteria; schwartz formula.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Receiver operating characteristic curve to diagnose efficacy of S. cystatin C and S. creatinine concentrations for prediction of acute kidney injury in critically-ill children by risk-injury-failure-loss-end stage renal disease classification (the upper) and Schwartz formula (the lower)
See this image and copyright information in PMC

References

    1. Joannidis M, Metnitz PG. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin. 2005;21:239–49. - PubMed
    1. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33:1563–70. - PubMed
    1. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005;51:1420–31. - PubMed
    1. Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant. 2005;20:747–53. - PubMed
    1. Jo SK, Rosner MH, Okusa MD. Pharmacologic treatment of acute kidney injury: Why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol. 2007;2:356–65. - PubMed

LinkOut - more resources